• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,061.08 860.40
( 1.13%)
Global Indices
Nasdaq
51,704.04 -29.67
(-0.06%)
Dow Jones
7,389.07 -104.72
(-1.40%)
Hang Seng
69,343.30 -445.08
(-0.64%)
Nikkei 225
10,454.55 16.70
(0.16%)
Forex
USD-INR
94.53 0.21
(0.22%)
EUR-INR
108.18 0.03
(0.03%)
GBP-INR
125.09 0.39
(0.31%)
JPY-INR
0.58 0.00
(0.06%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.3622252
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
33.63
115772.31
EPS(TTM)
Face Value()
Div & Yield %
42.61
2
0.91
 

Cemindia Projects consolidated net profit rises 113.63% in the March 2026 quarter
Apr 30,2026
Net profit of Cemindia Projects rose 113.63% to Rs 242.17 crore in the quarter ended March 2026 as against Rs 113.36 crore during the previous quarter ended March 2025. Sales rose 17.42% to Rs 2973.49 crore in the quarter ended March 2026 as against Rs 2532.34 crore during the previous quarter ended March 2025.

For the full year,net profit rose 60.34% to Rs 597.73 crore in the year ended March 2026 as against Rs 372.78 crore during the previous year ended March 2025. Sales rose 8.81% to Rs 10060.58 crore in the year ended March 2026 as against Rs 9246.16 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2973.492532.34 17 10060.589246.16 9
OPM %12.0310.07 -10.159.32 -
PBDT388.93208.12 87 983.51702.44 40
PBT350.25156.64 124 817.62507.99 61
NP242.17113.36 114 597.73372.78 60